Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M36.7Revenue $M16.0Net Margin (%)-76.7Z-Score-1.3
Enterprise Value $M26.1EPS $-0.4Operating Margin %-79.0F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-79.1Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %-11.0Quick Ratio2.7Cash flow > EarningsN
Price/Sales1.75-y EBITDA Growth Rate %-12.7Current Ratio3.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-33.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.3ROI % (ttm)-16.6Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$1.2 - $2.13
($1.73)
$ 0.91-90%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $1.91 - $2.47
($2.2)
$ 0.91-142%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rhein Denis MichaelDirector 2014-12-01Sell0$0 view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy22,500$2.3-60.43 view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy100$2.44-62.7 view
ENGLE J MELVILLECEO 2009-09-25Buy25,000$2.28-60.09 view
MCENANY PATRICK JDirector 2009-05-19Buy6,250$2.32-60.78 view
ENGLE J MELVILLECEO 2009-05-12Buy25,000$2.2-58.64 view
MCENANY PATRICK JDirector 2009-05-08Buy6,250$2.12-57.08 view
HUCKEL HUBERT E MDDirector 2007-11-16Buy36,500$7.8-88.33 view
SEGAL DANIELVP Sales & Marketing 2007-03-01Buy750$12.56-92.75 view
BARRY GEORGE JDirector 2006-05-12Buy250$16.28-94.41 view

Press Releases about KOOL :

    Quarterly/Annual Reports about KOOL:

    News about KOOL:

    Articles On GuruFocus.com
    comment on KOOL Dec 01 2011 
    comment on KOOL Aug 27 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 13 2009 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 

    More From Other Websites
    Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia (CLI)... Apr 10 2015
    Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia ("CLI")... Apr 10 2015
    Cesca to Present at the 2nd Annual Growth Capital Expo Apr 08 2015
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Apr 03 2015
    Delphi's autonomous car proof of concept: driving itself across the U.S. Mar 20 2015
    CESCA THERAPEUTICS TO PRESENT AT 3RD ANNUAL REGEN MED INVESTOR DAY Mar 19 2015
    Cesca Therapeutics to Present at 3rd Annual Regen Med Investor Day Mar 19 2015
    MicroCap Review Magazine Winter/Spring 2015 Issue Now Available Mar 04 2015
    CESCA THERAPEUTICS INC. Financials Mar 03 2015
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Feb 27 2015
    Cesca Therapeutics Receives Notice of Non-Compliance With Nasdaq Listing Rule Feb 27 2015
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Financial Statements and Exhibits Feb 17 2015
    CESCA THERAPEUTICS REPORTS SECOND QUARTER FISCAL 2015 RESULTS Feb 12 2015
    CESCA THERAPEUTICS TO ANNOUNCE SECOND QUARTER FISCAL 2015 RESULTS ON FEBRUARY 12, 2015 Feb 12 2015
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 12 2015
    Cesca Therapeutics Announces Approval of Its MarrowXpress(TM) System in India Feb 11 2015
    Cesca Therapeutics to Announce Second Quarter Fiscal 2015 Results on February 12, 2015 Feb 11 2015
    CESCA THERAPEUTICS TO PRESENT AT 17TH ANNUAL BIO CEO & INVESTOR CONFERENCE Feb 09 2015
    Cesca Therapeutics to Present at 17th Annual BIO CEO & Investor Conference Feb 09 2015
    3 technologies to watch from the Consumer Electronics Show Jan 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK